| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009.
|
J Clin Oncol
|
2012
|
3.34
|
|
2
|
Assessing the impact of a cooperative group trial on breast cancer care in the medicare population.
|
J Clin Oncol
|
2012
|
3.07
|
|
3
|
The relationship between clinical benefit and receipt of curative therapy for prostate cancer.
|
Arch Intern Med
|
2012
|
2.48
|
|
4
|
The association between diffusion of the surgical robot and radical prostatectomy rates.
|
Med Care
|
2011
|
2.38
|
|
5
|
Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system.
|
Oncology (Williston Park)
|
2012
|
2.29
|
|
6
|
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.
|
J Neurosurg
|
2012
|
2.28
|
|
7
|
Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
|
Urology
|
2013
|
2.16
|
|
8
|
Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
|
Med Care
|
2014
|
2.14
|
|
9
|
Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy.
|
Oncology (Williston Park)
|
2010
|
2.01
|
|
10
|
Population based cancer registry analysis of primary tracheal carcinoma.
|
Am J Clin Oncol
|
2011
|
1.71
|
|
11
|
A retrospective review of 1349 cases of sebaceous carcinoma.
|
Cancer
|
2009
|
1.70
|
|
12
|
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.59
|
|
13
|
Geographical information systems: applications and limitations in oncology research.
|
Oncology (Williston Park)
|
2011
|
1.52
|
|
14
|
Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care.
|
Med Care
|
2014
|
1.50
|
|
15
|
In regard to "Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series." (Int J Radiat Oncol Biol Phys 2012;83:624-629).
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.37
|
|
16
|
Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation.
|
Blood
|
2010
|
1.34
|
|
17
|
Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.25
|
|
18
|
Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis.
|
Cancer
|
2011
|
1.19
|
|
19
|
Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009.
|
Cancer
|
2014
|
1.18
|
|
20
|
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy.
|
Am J Clin Oncol
|
2011
|
1.16
|
|
21
|
The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population.
|
J Urol
|
2011
|
1.16
|
|
22
|
Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat.
|
Health Aff (Millwood)
|
2012
|
1.09
|
|
23
|
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma.
|
Radiother Oncol
|
2009
|
1.08
|
|
24
|
Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance.
|
Curr Probl Cancer
|
2012
|
1.04
|
|
25
|
Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.03
|
|
26
|
Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.02
|
|
27
|
The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.00
|
|
28
|
Analysis of pathologic extent of disease for clinically localized prostate cancer after radical prostatectomy and subsequent use of adjuvant radiation in a national cohort.
|
Cancer
|
2010
|
0.99
|
|
29
|
The cost implications of prostate cancer screening in the Medicare population.
|
Cancer
|
2013
|
0.95
|
|
30
|
A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer.
|
Clin Cancer Res
|
2013
|
0.93
|
|
31
|
Age, race, sex, stage, and incidence of cutaneous lymphoma.
|
Clin Lymphoma Myeloma Leuk
|
2012
|
0.92
|
|
32
|
Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma.
|
Br J Ophthalmol
|
2009
|
0.92
|
|
33
|
Limitations and biases of the Surveillance, Epidemiology, and End Results database.
|
Curr Probl Cancer
|
2012
|
0.91
|
|
34
|
Geographic analysis of the radiation oncology workforce.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.91
|
|
35
|
Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.
|
J Thorac Oncol
|
2015
|
0.90
|
|
36
|
Melanoma brain metastases: is it time to reassess the bias?
|
Curr Probl Cancer
|
2011
|
0.90
|
|
37
|
Adjuvant radiotherapy after radical prostatectomy: evidence and analysis.
|
Cancer Treat Rev
|
2010
|
0.89
|
|
38
|
Variation in receipt of radiation therapy after breast-conserving surgery: assessing the impact of physicians and geographic regions.
|
Med Care
|
2013
|
0.89
|
|
39
|
Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update.
|
Expert Rev Anticancer Ther
|
2011
|
0.87
|
|
40
|
Complications of brain tumors and their treatment.
|
Hematol Oncol Clin North Am
|
2012
|
0.86
|
|
41
|
National Residency Matching Program (NRMP) results for radiation oncology: 2011 update.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.86
|
|
42
|
Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy.
|
Semin Radiat Oncol
|
2014
|
0.85
|
|
43
|
National residency matching program results for radiation oncology: 2012 update.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.85
|
|
44
|
A prognostic index for predicting lymph node metastasis in minor salivary gland cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.84
|
|
45
|
A new approach to understanding racial disparities in prostate cancer treatment.
|
J Geriatr Oncol
|
2013
|
0.84
|
|
46
|
Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer.
|
J Natl Cancer Inst
|
2014
|
0.84
|
|
47
|
Testicular doses in image-guided radiotherapy of prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.82
|
|
48
|
A significant decrease in rectal volume and diameter during prostate IMRT.
|
Radiother Oncol
|
2011
|
0.82
|
|
49
|
Role of stereotactic radiosurgery in patients with more than four brain metastases.
|
CNS Oncol
|
2013
|
0.80
|
|
50
|
Stage I Lung SBRT Clinical Practice Patterns.
|
Am J Clin Oncol
|
2017
|
0.80
|
|
51
|
Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy: in regard to Gondi v, et al. (Int j radiat oncol biol phys 2010;78:1244-1252).
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.79
|
|
52
|
How radiation oncologists would disclose errors: results of a survey of radiation oncologists and trainees.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.79
|
|
53
|
Survival and intracranial control of patients with 5 or more brain metastases treated with gamma knife stereotactic radiosurgery.
|
Am J Clin Oncol
|
2013
|
0.79
|
|
54
|
Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database.
|
J Surg Res
|
2013
|
0.78
|
|
55
|
Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence.
|
Am J Clin Oncol
|
2016
|
0.78
|
|
56
|
Significance of histology in determining management of lesions regrowing after radiosurgery.
|
J Neurooncol
|
2014
|
0.78
|
|
57
|
Using the Surveillance, Epidemiology, and End Results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes.
|
Curr Probl Cancer
|
2012
|
0.77
|
|
58
|
Reply to L.W. Cuttino et al.
|
J Clin Oncol
|
2013
|
0.77
|
|
59
|
The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme.
|
J Neurooncol
|
2013
|
0.77
|
|
60
|
Role of neurosurgery and radiation therapy in the management of brain tumors.
|
Hematol Oncol Clin North Am
|
2012
|
0.76
|
|
61
|
Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
|
Int J Gynecol Cancer
|
2015
|
0.76
|
|
62
|
Breast cancer brain metastases: one step at a time.
|
Oncology (Williston Park)
|
2014
|
0.75
|
|
63
|
The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer.
|
J Geriatr Oncol
|
2013
|
0.75
|
|
64
|
The prognostic importance of midline involvement in oral tongue cancer.
|
Am J Clin Oncol
|
2012
|
0.75
|
|
65
|
Impact of immediate postoperative death on the estimation of a survival benefit from postoperative radiation therapy for cancer of the gallbladder.
|
J Clin Oncol
|
2008
|
0.75
|
|
66
|
Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study.
|
J Neurosurg
|
2014
|
0.75
|
|
67
|
Response.
|
J Natl Cancer Inst
|
2013
|
0.75
|
|
68
|
Chemoradiation Therapy for Organ Preservation in Localized Male Urethral Carcinoma.
|
Oncology (Williston Park)
|
2016
|
0.75
|
|
69
|
Academic and Resident Radiation Oncologists' Attitudes and Intentions Regarding Radiation Therapy near the End of Life.
|
Am J Clin Oncol
|
2016
|
0.75
|
|
70
|
Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009.
|
Am J Clin Oncol
|
2016
|
0.75
|
|
71
|
Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type.
|
Am J Clin Oncol
|
2017
|
0.75
|
|
72
|
National Residency Matching Program (NRMP) results for radiation oncology: 2007 update.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.75
|
|
73
|
Stereotactic radiosurgery of petroclival meningiomas: a multicenter study.
|
J Neurooncol
|
2014
|
0.75
|
|
74
|
National residency matching program (NRMP) results for radiation oncology: 2010 update.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.75
|
|
75
|
The daily miracle of palliative radiotherapy for prostate cancer.
|
Oncology (Williston Park)
|
2014
|
0.75
|
|
76
|
Determinants of enrollment in cancer clinical trials: the relationship between the current state of knowledge, societal disease burden, and randomized clinical trial enrollment.
|
J Natl Compr Canc Netw
|
2013
|
0.75
|
|
77
|
Comparative Effectiveness Research and the Surveillance, Epidemiology, and End Results database: what is Comparative Effectiveness Research (CER) and why is it important?
|
Curr Probl Cancer
|
2012
|
0.75
|
|
78
|
Prediction models, nomograms, and staging validation with the Surveillance, Epidemiology, and End Results database: using Surveillance, Epidemiology and End Results (SEER) program to create prediction models.
|
Curr Probl Cancer
|
2012
|
0.75
|
|
79
|
Proton radiotherapy for prostate cancer: how did we get here, and where do we go from here?
|
Oncology (Williston Park)
|
2013
|
0.75
|
|
80
|
POINT-Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy?
|
Oncology (Williston Park)
|
2017
|
0.75
|